InvestorsHub Logo
Followers 618
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: loanranger post# 348491

Tuesday, 02/23/2021 3:48:27 PM

Tuesday, February 23, 2021 3:48:27 PM

Post# of 402566
The information from new Sonis article is likely dealing with previous ph2 Brilacidin OM trial based on what I find.

https://scholar.google.com/scholar?as_ylo=2021&q=brilacidin+%2B+oral+mucositis+%2B+2021&hl=en&as_sdt=0,5

Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development
ST Sonis - Current Treatment Options in Oncology, 2021 - Springer
phase 2 trial was completed in patients receiving CRT for cancers of the mouth and oropharynx (Phase 2 Study to Evaluate the Efficacy & Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients With Head …



If I change the search to simply Brilacidin + 2021 I find the following which I believe also discusses covid trial.

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&as_ylo=2021&q=brilacidin+%2B+2021&btnG=

Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development
ST Sonis - Current Treatment Options in Oncology, 2021 - Springer
being assessed in the ongoing trial. Enrollment is expected to be completed in Q1 of 2021. Small molecules targeting NF-?B and pro-inflammatory cytokine production. Brilacidin. Brilacidin is a fully synthetic defensin mimetic …



Both of above are same article with slightly differing descriptions.

It will be interesting to see the actual article. I'm unable to access without a purchase.

LitesOut... thanks for ordering it. ;)











Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News